Evaluation of antiangiogenic and antiproliferative potential in ethanolic extract of dioscoria bulbifera L

Current Trends in Biotechnology and Pharmacy

Volumn 4, Issue 4, 2010, Pages 930-940

  Kaveri, K ^a   Yashaswini, B ^a   Sheela, M L ^a   Salimath, Bharathi P ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

Angiogenesis; Anti proliferation; CAM; D.bulbifera; Matrigel; Rat cornea; VEGF

Indexed keywords

DIOSCORIA BULBIFERA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DIOSCOREACEAE; DIOSCORIA BULBIFERA; DRUG EFFICACY; DRUG SCREENING; EHRLICH ASCITES TUMOR; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; TRADITIONAL MEDICINE;

MUS; RATTUS;

EID: 78049522546     PISSN: 09738916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Auerbach, W. and Auerbach, R. (1994). Angiogenesis inhibition: a review. Pharmacology and Therapeutics, 63:265-311.
2. Hanahan, D. and Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364.
3. Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine, 1: 27-31.
4. Risau, W. (1997). Mechanisms of angiogenesis. Nature (Lond.), 386: 671-674.
5. Folkman, S. and Chesney, M. (1997). Grief Vancouver Conference Review. AIDS Care, 9:39-43.
6. Bussolino, F., Mantovani, A. and Persico, G. (1997). Molecular mechanisms of blood vessel formation. Trends in Biochemical Science, 22: 251-256.
7. Inser, J. M. and Asahara, T. (1999). Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. Journal of Clinical Investigation, 103: 1231-1236.
8. Sheela, M. Lingaraju., Kaveri Keshavaiah. and Bharathi P. Salimath. (2008). Inhibition of in vivo angiogenesis by Anacardium occidentale L. involves repression of the cytokine VEGF gene expression. Drug Discovery and Therapeutics, 2(4): 234-244.
9. Bonham, M., Arnold, H., Montgomery, B. and Nelson, P.S. (2002). Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma. Cancer Research,62: 3920-3942.
10. Hu, H., Ahn, N.S., Yang, X., Lee, Y.S. and Kang, K.S. (2002). Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast. International Journal of Cancer, 102: 250-253.
11. Kao, S.T., Yeh, C.C., Hsieh, C.C., Yang, M.D., Lee, M.R. and Liu, H.S. (2001). The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell ines by inducing apoptosis via G0/G1 arrest. Life Science, 69:1485-1496.
12. Lee, S.M., Li, M.L., Tse, Y.C., Leung, S.C., Lee, M.M. and Tsui, S.K. (2002). Paeoniae Radix, a Chinese herbal extract, inhibits hepatoma cell growth by inducing apoptosis in a p53 independent pathway. Life Science, 71: 2267-2277.
13. Deepak, A.V. and Salimath, B.P. Antiangiogenic and proapoptotic activity of a novel glycoprotein from Urgigia indica is mediated by NF-êB and Caspase activated DNase in ascites tumor model. Biochimie; 88: 297-307, 2005.
14. Belakawadi, M and Salimath, B.P. (2005). Mechanism of inhibition of ascites tumor growth in mice by curcumin is mediated by NF-êB and Caspase activated DNase. Molecular and Cellular Biochemistry; 273: 57-67.
15. Thippeswamy, G. and Salimath, B.P. (2007). Induction of caspase-3 activated DNase mediated apoptosis by hexane fraction of Tinospora cordifolia in EAT cells. Environmental Toxicology and Pharmacology, 23: 212-220.
16. Dulak, J. (2005). Nutraceuticals as antiangiogenic agents: hopes and reality. Journal of Physiology and Pharmacology, 56:51-69.
17. Kerbel, R.S. (2000). Tumor angiogenesis: past, present and the near future. Carcinogenesis, 21: 505-515.
18. Shriram, V., Jahagirdar, S., Latha, C. Kumar., Puranik, V., Rojatkar, S., Dhakephalkar, P.K. and Shitole, M.G. (2008). A potential plasmidcuring agent, 8-epidiosbulbin E acetate, from Dioscoria bulbifera L. Aganist multidrugresistantbacteria. International Journal of Antimicrobial Agents, November, 32(5): 405-410.
19. Zhong Yao Cai. (2007). Extraction and antitumor activity study of polysaccharide in several traditional Chinese medicines. Journal of Traditional Chinese Medicine, February, 30(2):179-182.
20. Yingjuan Yao., Wanlun Cai., Changju Yang., Dong Xue and Yanzhang Huang. (2008). Isolation and characterization of insecticidal activity of (Z)-asarone from Acorus calamus L. Insect Science, 15:229-236.
21. Au, T. S., Wiart, M. Y., Hassan, C. H., Hanifah, Y. A. and Kamaruddin, M. Y. (2008). Antibacterial Activity of Annona squamosa Linnaeus (Annonaceae). Insect Science, 15: 7-10.
22. Rastogi, R.P. and Dhawan, B.N. (1990). Anticancer and antiviral activities in Indian medicinal plants: a review. Drug Development Research, 19: 1-12.
23. Kirtikar, K.R. and Basu, B.D. (1933). Indian Medicinal Plants, Allahabad: Lalit Mohan Basu Publications, 3: 2291.
24. Rao, Y.K., Fang, S.H. and Tzeng, Y.M. (2008). Anti-inflammatory activities of flavonoids and a triterpene caffeate isolated from Bauhinia variegata. Phytotherapy Research, July, 22(7):957-962.
25. Rajkapoor, B., Jayakar, B. and Murugesh, N. (2003). Antitumor activity of Bauhinia variegata on Dalton's ascetic lymphoma. Journal of Ethnopharmacology, November, 89(1): 107-109
26. Boonsri, S., Karalai, C., Ponglimanont, C., Chantrapromma, S. and Kanjana-Opas, A. (2008). Cytotoxic and antibacterial sesquiterpenes from Thespesia populnea. Journal of Natural Products, July, 71(7): 1173-1177.
27. Vasudevan, M., Gunnam, K.K. and Parle, M. (2007). Antinociceptive and antiinflammatory effects of Thespesia populnea bark extract. Journal of Ethno pharmacology., January 19, 109(2): 264-270.
28. Vasudevan, M. and Parle, M. (2006). Pharmacological actions of Thespesia populnea relevant to Alzheimer's disease. Phytomedicine, November,13(9-10):677-687.
29. Bajpai, M., Pande, A., Tewari, S.K. and Prakash, D. (2005). Phenolic contents and antioxidant activity of some food and medicinal plants. International Journal of Food Science and Nutrition, June 56(4): 287-291
30. Salimath, B.P., Tabassum, A., Anupama, E.G., Bindumalini Peethi, G.B. and Salimath, PV. (1999). Molecular mechanism of action of butyric acid in Ehrlich Ascites Tumor cells. Nutritional Research, 19:589-560.
31. Sarayba, M.A., Li, L., Tungsiripat, T., Liu, N.H., Sweet, P.M. and Patel, A.J. (2005). Inhibition of corneal neovascularizaion by a peroxisome proliferators-activated receptorã ligand. Experimental Eye Research, 80: 435-442.
32. Gururaj, A.E., Belakavadi, M. and Salimath, B.P. (2003). Antiangiogenic effects of butyric acid involve inhibition of VEGF/KDR gene expression and endothelial cell proliferation. Molecular Cell Biochemistry, 243:107-112.
33. Belakavadi, M. and Salimath, B.P. (2005). Mechanism of inhibition of ascites tumor growth in mice by curcumin is mediated by NF-kB and caspase activated DNase. Molecular and Cellular Biochemistry, 273:57-67.
34. Ashton, A.W., Yokota, R. and John, G. (1999). Inhibition of endothelial cell migration, intercellular communication and vascular tube formation by thromboxane A. Journal of Biology and Chemistry, 274:35562-35570.
35. Tai, J., Cheunga, S., Chanb, E. and Hasmanb, D. (2004). In vitro culture studies of Sutherlandia frutescens on human tumor cell lines. Journal of Ethno pharmacology, 93:9-19.
36. Sadick, H., Naim, R., Gossler, U., Hormann, K. and Riedel, F. (2005). Angiogenesis in hereditary hemorrhagic telangiectasia: VEGF165 plasma concentration in correlation to the VEGF expression and microvessel density. International Journal of Molecular Medicine, 15:15-19.
37. Mesiano, S., Ferrara, N. and Jaffe, R.B. (1998). Role of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibition of Ascites Formation by Immunoneutralization. American Journal of Pathology, 153: 1249-1256.
38. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S. and Ferrara, N. (1993). Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumor growth in-vivo. Nature, 362: 841-844.
39. Prabhakar, B.T., Khanum, S.A., Shashikanth, S. and Salimath, B.P. (2006). Antiangiogenic effect of 2-benzoyl-phenoxy acetamide in EAT cell is mediated by HIF- 1 á and down regulation of VEGF in vivo. Investigation of New Drugs, 24: 471-478.